-
Curaleaf's Dual Expansion: Balancing Medical And Recreational Markets While Emphasizing Social Equity (CORRECTED)
Monday, May 13, 2024 - 3:20pm | 615Read More...Editor’s note: This story has been corrected to reflect that Curaleaf is headquartered in New York City. Curaleaf CEO Matt Darin told Benzinga at the Cannabis Capital Conference in Miami that the company has recently increased its presence in New York. The New York City-based...
-
Private Equity Firms Buy A Majority Stake In Medline For More Than $30 Billion
Sunday, June 6, 2021 - 11:59am | 536Read More...A consortium of private equity firms bought a majority stake in medical supplier Medline Industries Inc, which according to sources familiar with the matter, is a deal valued at more than $30 billion. What Happened: Private equity firms comprising of Blackstone Group Inc (NYSE:...
-
After FDA Rejects Acadia Dementia Drug, Analysts Lament Lack Of Near-term Stock Drivers
Tuesday, April 6, 2021 - 5:36pm | 694Read More...ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares came under pressure Monday after the Food and Drug Administration (FDA) rejected its regulatory application seeking label expansion for its dementia drug. The Acadia Analysts: Goldman Sachs analyst Salveen Richter downgraded Acadia shares...
-
ICAD Focuses On Areas Of High Unmet Need In Cancer Detection, BTIG Says
Tuesday, March 23, 2021 - 2:39pm | 284Read More...ICAD Inc (NASDAQ: ICAD) is poised to benefit in the long term from its AI-driven cancer detection tools and electronic brachytherapy product, according to BTIG. The iCAD Analyst: Marie Thibault initiated coverage of iCAD with a Buy rating and a price target of $25. The iCAD Thesis: The company...
-
3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy
Tuesday, March 16, 2021 - 11:41am | 927Read More...Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a $1.8 billion deal on Monday, the same day Veracyte Inc (NASDAQ: VCYT) announced it completed the acquisition of Decipher Biosciences, Inc. What Happened: With the cancer...
-
Deutsche Bank Downgrades Hologic, Says Core Businesses Face Structural Challenges
Friday, January 19, 2018 - 11:05am | 428Read More...Medical diagnostics products maker Hologic, Inc. (NASDAQ: HOLX) is likely to be stifled by secular growth challenges on multiple fronts, Deutsche Bank said in a Thursday note. The Analyst Deutsche Bank analyst Dan Leonard downgraded shares of Hologic from Buy to Neutral with a $46 price...
-
Are We Bidding Farewell to Paid Mobile Apps?
Thursday, October 3, 2013 - 1:34pm | 571Read More...According to Flurry Analytics, the percentage of paid apps on the App Store fell from 20 percent in 2011 to 10 percent in 2013. That’s a 10 percent drop in two years, and the trend is likely to continue. In general, Flurry said, people seemed to want free content even if it meant putting up...
-
BPAX Reaches Key LibiGel® Safety Study Enrollment Target
Monday, October 18, 2010 - 12:28pm | 1399Read More...LINCOLNSHIRE, Ill. - October 18, 2010 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers...
-
Biotech Stocks Trading High Volume (UVFT.OB, KBLB.OB, SGEN, GENZ)
Monday, September 27, 2010 - 2:09pm | 1141Read More...Point Roberts, WA - September 27, 2010 (Investorideas.com Newswire, www.biotechindustrystocks.com ) - InvestorIdeas.com, a leader in sector research for investors, reports on recent Volume Leading Biotech/ Pharma Stocks news and trading for September 27th on the OTCBB and NASDAQ Markets. Top...
-
Biotech Stock Alert; (OTCBB: UVFT) Reports Air Purifier Technology Fights Superbugs NDM-1
Monday, September 27, 2010 - 10:41am | 1203Read More...CENTERVILLE, MA--(Investorideas.com newswire, www.biotechindustrystocks.com ) – Biotechnology Company News- UV Flu Technologies, Inc. (OTC.BB:UVFT ) recently announced news that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly...
-
BioSante Pharmaceuticals (NASDAQ: BPAX), Inc. To Present at the JMP Healthcare Conference
Wednesday, September 22, 2010 - 11:51am | 534Read More...LINCOLNSHIRE, Ill. - September 22, 2010 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) will present at the JMP Healthcare Conference being held in the New York Palace Hotel, New York City from September 27-28, 2010 Phillip B. Donenberg, BioSante's senior vice president...
-
Healthcare Technology Stocks Sector Close –Up; (OTCBB: HEME), (OTCBB: CYCA), (NASDAQ:HSTM), (NASDAQ:MDRX)
Friday, September 3, 2010 - 1:12pm | 644Read More...Point Roberts, WA (Investorideas.com Newswire) September 3, 2010- InvestorIdeas.com, leader in sector research for investors, reports on recent Healthcare Technology Stocks news and trading for September 3rd. Healthcare Technology Stocks include Healthmed Services Ltd. (OTCBB: HEME), Cytta Corp. (...
-
BioSante Pharmaceuticals (NASDAQ: BPAX) Company Profile at Investorideas.com
Tuesday, August 24, 2010 - 10:29am | 672Read More...August 24, 2010 –(Investorideas.com newswire) www.InvestorIdeas.com, an investor research portal covering multiple sectors including biotech stocks and pharma stocks, announces the new company profile for pharma stock BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) for interested investors....








